CNRS - AIX MARSEILLE UNIV: UMR7257

Home page > en > Research > Teams > Viral Replicases: Structure, function and drug-design

Viral Replicases: Structure, function and drug-design

Head Bruno CANARD

Latest Publications

  1. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. (2020) Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. Antiviral Res in press 104742 PMID:32057769
  2. Design, synthesis and discovery of novel N,N'-carbazoyl-aryl-urea inhibitors of Zika NS5 methyltransferase and virus replication. (2019) Spizzichino S, Mattedi G, Lauder K, Valle C, Aouadi W, Canard B, Decroly E, Kaptein SJF, Neyts J, Graham C, Sule Z, Barlow DJ, Silvestri R, Castagnolo D. ChemMedChem in press PMID:31805205
  3. Structure of the Respiratory Syncytial Virus Polymerase Complex. (2019) Gilman MSA, Liu C, Fung A, Behera I, Jordan P, Rigaux P, Ysebaert N, Tcherniuk S, Sourimant J, Eleouet JF, Sutto-Ortiz P, Decroly E, Roymans D, Jin Z, McLellan JS. Cell 179 193-204 PMID:31495574
  4. The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity. (2019) Ogando NS, Ferron F, Decroly E, Canard B, Posthuma CC, Snijder EJ. Front Microbiol 10 1813 PMID:31440227
  5. Structure and oligomerization state of the C-terminal region of the Middle East respiratory syndrome coronavirus nucleoprotein. (2019) Nguyen THV, Lichiere J, Canard B, Papageorgiou N, Attoumani S, Ferron F, Coutard B. Acta Crystallogr D Struct Biol 75 8-15 PMID:30644840
  6. Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain (2019) Saez-Ayala M, Laban Yekwa E, Mondielli C, Roux L, Hernandez S, Bailly F, Cotelle P, Rogolino D, Canard B, Ferron F, Alvarez K. Antiviral Res. 162 79-89 PMID:30557576
...All publications

Our team seeks to unravel the molecular mechanisms of emerging viruses by characterizing the structures and the enzymatic activities of proteins forming the viral replication and transcription complex. These studies are a prerequisite for the development of specific inhibitors of these enzymes and should allow the development of new antiviral strategies.

RNA viruses are often associated with the emergence of infectious diseases. Among the best known, epidemics related to Ebola, SARS coronavirus and MERS, chikungunya or dengue virus illustrate the worldwide public health concern related to viral infections. The team "Viral replicase: structure, mechanism and drug-design" characterizes enzymes and proteines from emerging viruses involved in the replication of their genome and transcription of their messenger RNAs. These enzymes are associated in a replication/transcription complex (RTC). Our studies focus not only on viral polymerases that are at the heart viral replication, but also on the enzymes involved in RNA modifications such as capping and proofreading and proteins involved in the regulation of replication. Beyond the study of the RTC, we are also interested in the interplay of these enzymes with the innate immunity defence mechanism of the cell. The viral replication proteins are privileged antiviral targets and understanding of their structure and function is essential for the design of antiviral molecules with a high potential. To support these research projects, the lab benefits from the support of an inhibitor-screening platform (PCML) and a platform dedicated to the expression of recombinant viral proteins.


Karine ALVAREZ
Bruno CANARD
UNK
Alice DECOMBE
Etienne DECROLY
UNK
Priscila EL-KAZZI
Cécilia EYDOUX
Véronique FATTORINI
UNK
Mikael FERACCI
François FERRON
UNK
Laura GARLATTI
Jean-Claude GUILLEMOT
Sergio HERNANDEZ
Rafik KACI
Nhung LE
Oney ORTEGA-GRANDA
Nicolas PAPAGEORGIOU
Nadia RABAH
Bhawna SAMA
Barbara SELISKO
Ashleigh SHANNON
Priscila SUTTO-ORTIZ
Coralie VALLE

© AFMB UMR7257  W3C validation